NivolumabImmune related diarrhoea and treatment failure: 5 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1899卷 / 1期

关键词：

D O I：

10.1007/s40278-022-12278-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：306 / 306

相关论文

共 50 条

[1] NivolumabImmune-related pneumonitis: 2 case reports
Reactions Weekly, 2020, 1792 (1) : 175 - 175
[2] NivolumabImmune related neurological complications: 4 case reports
Reactions Weekly, 2020, 1797 (1) : 188 - 188
[3] NivolumabImmune-related thyroiditis: 6 case reports
Reactions Weekly, 2018, 1727 (1) : 213 - 213
[4] NivolumabImmune-related pneumonitis: 16 case reports
Reactions Weekly, 2023, 1946 (1) : 433 - 433
[5] NivolumabImmune-related adverse reactions: 2 case reports
Reactions Weekly, 2020, 1790 (1) : 172 - 172
[6] Ipilimumab/NivolumabImmune checkpoint inhibitor-related diarrhoea and colitis: case report
Reactions Weekly, 2020, 1818 (1) : 153 - 153
[7] NivolumabImmune-related adverse events: 19 case reports
Reactions Weekly, 2019, 1764 (1) : 251 - 251
[8] NivolumabImmune-related adverse events: 12 case reports
Reactions Weekly, 2020, 1785 (1) : 392 - 392
[9] Ipilimumab/nivolumabImmune-related hepatitis: 2 case reports
Reactions Weekly, 2020, 1807 (1) : 104 - 104
[10] Ipilimumab/nivolumabImmune-related pneumonitis: 2 case reports
Reactions Weekly, 2020, 1813 (1) : 137 - 137

← 1 2 3 4 5 →